New dates for the postponed event are still being determined.
Reed Exhibitions announced on March 11, 2020 that it was rescheduling its pharmaceutical industry event, INTERPHEX- originally scheduled to take place April 28–30 at the Javits Center in New York City-to July 15–17 at the same location because of concerns surrounding COVID-19.
“We know how important INTERPHEX is to our customers’ business and it is our top priority to provide the forum for INTERPHEX and Chemspec USA to allow business to continue,” said Randy Field, group vice president, Reed Exhibitions, in the press release. “The INTERPHEX community is uniquely equipped to support authorities and have a positive impact on addressing the COVID-19 virus. Therefore, we’ve made the decision to postpone INTERPHEX 2020 to July 15–17, 2020. We believe this is the right decision for our customers and the industry in general, which is a vital part of getting the pharmaceutical supply chain back on track post-outbreak.”
“We are working with our partners to find solutions to logistical and operational issues that may arise," Field added. "We are here to help, but ask for your patience as we ensure all of our customers are taken care of. With that in mind, please make sure to change hotels, flights, and any other arrangements. Information regarding airline change fee waivers is available on our website.”
Source: Reed Exhibitions
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.